Patent ID: 9186349
Filing Date: 2015-11-17
Classification: A61K,A61N,A61P

Abstract:
1. A method of treating cancer, a cancer-associated disorder, inflammation or an inflammation -associated disorder, the method comprising: (i) administering to a patient a therapeutically effective amount of a phototherapeutic agent to a target tissue of said patient, the phototherapeutic agent comprising a compound being of the formula (FX38); and (ii) exposing the phototherapeutic agent administered to the patient at the target tissue to electromagnetic radiation having wavelengths selected over the range of 350 nm and 1300 nm sufficient to result in injury or death to cells at the target tissue; wherein each of R each of R R wherein the exposing cleaves the N—N bond forming two N radicals; and wherein the method is a Type 1 phototherapy procedure.